Quarterly Journal of Nuclear Medicine and Molecular Imaging

Papers
(The TQCC of Quarterly Journal of Nuclear Medicine and Molecular Imaging is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Osteomyelitis in complicated bones: the role of FDG PET/CT18
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study14
Role of 18F-FDG-PET/CT in assessment of pediatric Hodgkin's lymphoma14
Nuclear cardiac imaging for the diagnosis and management of heart failure: what can be learned from recent guidelines?12
Targeted alpha therapy in prostate cancer: review of available agents in clinical practice12
Current radioisotopes and radiopharmaceuticals for radiosynoviorthesis: basic and applied characteristics, production and availability12
Pediatric nuclear medicine: continuing the evolution11
Combination prostate-specific membrane antigen-targeted radiopharmaceutical therapy in metastatic prostate cancer9
[68Ga]DOTA-TATE PET for the detection of early transplant rejection in a heterotopic allograft heart transplantation model of the rat: a pilot study9
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus8
Hybrid positron emission tomography/magnetic resonance imaging in musculoskeletal conditions: be hybrid!8
The value of artificial intelligence in PSMA PET: a pathway to improved efficiency and results8
The role of PET/CT in large vessel vasculitis and related disorders: diagnosis, extent evaluation and assessment of therapy response7
[18F]F-Choline PET/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies?7
[18F]FDG and [68Ga]Ga-PSMA dual-tracer total-body PET/CT and PET/MR in patients with prostate cancer6
Second radioiodine treatment hardly benefits TT-DTC patients with radioiodine-negative metastases on initial post-therapeutic whole-body scans6
Stereotactic body radiation therapy for the re-irradiation of local relapse from prostate cancer: results in terms of outcomes and toxicity6
Theragnostics before we found its name6
Volumetric PET parameters are predictive for the prognosis of locally advanced cervical cancer5
Radiation protection aspects for alpha therapies5
FDG PET/CT in vascular graft infection: a pictorial review5
Perceptual omission errors in positron emission tomography and computed tomography reporting4
Technical concepts on blood pool phase SPECT (acquisition, reconstruction)4
Challenges in theragnostics4
The role of [18F]FDG PET/CT in paraneoplastic autoimmune disorders: an umbrella review4
Nuclear medicine and pediatric nephro-urology: a long-lasting successful partnership4
Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma4
Imaging of dopamine transporter with [18F]LBT-999: initial evaluation in healthy volunteers4
Adverse effects under immune checkpoint inhibitors on [18F]FDG PET/CT imaging4
Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors3
Towards refining the utility of dual (18F-FDG / 18F-Choline) PET/CT for the management of hepatocellular carcinoma: a tertiary center study3
Side effects of theragnostic agents currently employed in clinical practice3
Fever of unknown origin in pediatrics: role of nuclear medicine3
Theragnostics applications and challenges3
11C-methionine PET/MRI in postoperative patients after craniotomy: zero echo time and head atlas versus CT-based attenuation correction3
Benefit of including CT urography in [68Ga]PSMA-11 PET/CT with low-dose CT: first results from a larger prostate cancer cohort analysis3
The revolution of prostate cancer management with nuclear medicine: transforming diagnosis and treatment2
Emerging topics in neuroimaging2
[18F]FDG PET/CT for the diagnosis of diabetic foot osteomyelitis2
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study2
Detection, resection and cure: a systematic review and meta-analysis of 18F-choline PET in primary hyperparathyroidism2
FDG PET/CT for imaging of infection and inflammation: a practical approach2
Total variation regularized expectation maximization reconstruction improves 68Ga-FAPI-04 PET/CT image quality as compared to ordered subset expectation maximization reconstruction2
Innovations in imaging modalities: a comparative review of MRI, long-axial field-of-view PET, and full-ring CZT-SPECT in detecting bone metastases2
Evaluation and clinical quantification of neoplastic lesions and physiological structures in TOF- versus non-TOF-PET/MRI: a pilot study2
Radiosynoviorthesis: almost seventy years of experience but still somewhat fameless2
Dual-tracer 99mTc-sestamibi/ 123I imaging in primary hyperparathyroidism2
Predictive value of 18F-fluorodeoxyglucose PET/CT in histological grade of incidental colorectal adenoma2
Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma2
F18-FET PET in pediatric brain tumors: integrative analysis of image derived parameters and clinico-pathological data2
Local treatment of synovitis2
18F-FDG-PET/CT imaging of uterine cervical cancer recurrence in women with and without HIV infection2
Next-level precision medicine: why the theragnostic approach is the future2
18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center2
Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET/CT. Illustrative cases and pitfalls2
0.13247299194336